BioAge Labs, Inc. Segments Disclosure
Note 13. Segment Reporting
The Company has one reportable segment, which is the business of extending healthy human life by targeting molecular causes of aging.
The Company’s . When evaluating the Company's financial performance, the CODM reviews total operating expenses and expense by function to make decisions on a company-wide basis.
As a single reportable segment entity, the determined measure of profit or loss is the Company’s consolidated net income (loss). Consolidated asset information for the Company’s single reportable segment is presented in the Company’s consolidated balance sheets.
The table below is a summary of the segment net loss, including significant segment expenses:
|
|
Year Ended December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
|
$ |
8,995 |
|
|
$ |
— |
|
|
Segment expenses: |
|
|
|
|
|
|
||
Direct program costs |
|
|
49,449 |
|
|
|
37,132 |
|
Indirect research and development expenses |
|
|
24,517 |
|
|
|
21,904 |
|
General and administrative |
|
|
27,809 |
|
|
|
19,158 |
|
Total operating and segment expenses |
|
$ |
101,775 |
|
|
$ |
78,194 |
|
Loss from operations |
|
$ |
(92,780 |
) |
|
$ |
(78,194 |
) |
Interest and other income (expense), net |
|
|
12,175 |
|
|
|
7,085 |
|
Segment and consolidated net loss |
|
$ |
(80,605 |
) |
|
$ |
(71,109 |
) |
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 24, 2026 | Showing above |
| 2024 | Mar 20, 2025 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.